Activities of bone morphogenetic proteins in prolactin regulation by somatostatin analogs in rat pituitary GH3 cells [PDF]
, 2011 Involvement of the pituitary BMP system in the modulation of prolactin (PRL) secretion regulated by somatostatin analogs, including octreotide (OCT) and pasireotide (SOM230), and a dopamine agonist, bromocriptine (BRC), was examined in GH3 cells.
Inagaki, Kenichi +8 more
core +1 more source
Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study.
European Journal of EndocrinologyOBJECTIVE Elucidate the efficacy (as per current biochemical criteria) of cabergoline monotherapy or as addition to long-acting somatostatin receptor ligand (SRL) in patients with acromegaly and no previous pituitary radiotherapy.
Sandrine A Urwyler +9 more
semanticscholar +1 more source
Gazi Medical JournalObjective: To investigate the efficacy of the dopamine agonist cabergoline in uncontrolled acromegaly despite long-acting somatostatin analog (SSA). Methods: Thirty-five patients with acromegaly who were followed up in the department of endocrinology ...
Mehmet Muhittin Yalçın +13 more
doaj +1 more source
Cabergoline-induced tricuspid regurgitation: Case report and review of literature
Indian Journal of Endocrinology and Metabolism, 2011 The increased risk of cardiac valve disease in patients treated for Parkinson′s disease with cabergoline has raised concerns about the safety of treatment with ergot-derived dopamine agonists in patients with endocrine diseases, especially prolactinoma ...
Mohammad Hayat Bhat +4 more
doaj +1 more source
De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
Clinical Medicine Insights: Case Reports, 2023 Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low.
Chayma Belhadj Slimane +4 more
doaj +1 more source
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas. [PDF]
, 2014 Multiple endocrine neoplasia type 1 (MEN1) is a hereditary syndrome associated with the development of many endocrine tumors, involving mainly pituitary, parathyroids, pancreas, although a proliferative state interests all neuroendocrine system.
Camera, L +9 more
core +1 more source
Impulse Control Disorders in Southern Iraqi Patients Medicated With Cabergoline for Prolactinoma
CureusBackground: Among the patient population in Basrah, Iraq, prolactinoma is the most commonly found pituitary tumor. Impulse control disorders (ICDs) were reportedly associated with these patients being treated with cabergoline.
Mohammad M Mohammad +2 more
semanticscholar +1 more source
Structures of cabergoline anhydrate form II and novel cabergoline solvates
Structural Chemistry, 2006 Crystal forms of N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8β-carboxamide (cabergoline) originating from various solvents have been examined by X-ray diffraction at 298 or 150 K. Crystal structures of cabergoline anhydrate, (form II, P212121) and solvates (all P212121) with tert-butyl methyl ether (form VIII), cyclohexane (form XV)
Bohumil Kratochvíl +6 more
openaire +4 more sources
Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
Case Reports in Endocrinology, 2013 Although advances in endocrinologic and neuroradiologic research allow easier recognition of pituitary adenomas, giant pituitary tumours are relatively rare.
Emre Bozkirli +5 more
doaj +1 more source
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. [PDF]
, 2013 OBJECTIVE: Currently available studies that fully analyse the metabolic parameters in patients with prolactinoma are scarce and discordant. The aim of this study was to evaluate the metabolic effects of cabergoline (CAB) treatment in patients with newly
AMATO, Marco Calogero +4 more
core +1 more source